首页 | 本学科首页   官方微博 | 高级检索  
检索        

多药耐药基因在初治和复发的急性白血病中的表达
引用本文:蒋宜彬,张萍,于燕,王申五,王德炳.多药耐药基因在初治和复发的急性白血病中的表达[J].北京大学学报(医学版),1996(6).
作者姓名:蒋宜彬  张萍  于燕  王申五  王德炳
作者单位:北京医科大学人民医院血液病研究所
摘    要:目的:了解肿瘤细胞对多种化疗药物的耐受即多药耐药(MDR)是否与多药耐药基因(mdrl)的表达增高有关。方法:用人mdrl探针,采用原位杂交的方法分析了30例急性白血病患者mdrl基因表达水平。结果:治疗后未缓解或复发的急性白血病患者的mdrl基因表达水平明显高于治疗前患者(P<0.001)及治疗后完全缓解患者(P<0.01)。结论:mdrl基因的表达增高促进急性白血病临床化疗耐受。mdrl基因表达水平的增高是难治性和复发的急性白血病患者治疗难以缓解的原因之一,无论是初治或治疗后患者mdrl基因表达水平的增高常预示着预后差。

关 键 词:基因表达  药物耐受性  白血病/遗传学  

EXPRESSION OF MULTIDRUG RESISTANCE GENE IN PRIMARY AND THE RELAPSED STATE ACUETE LEUKEMIAS
JIANG Yibin,ZHANG Ping,YU Yan,WANG Shenwu,WANG Debing.EXPRESSION OF MULTIDRUG RESISTANCE GENE IN PRIMARY AND THE RELAPSED STATE ACUETE LEUKEMIAS[J].Journal of Peking University:Health Sciences,1996(6).
Authors:JIANG Yibin  ZHANG Ping  YU Yan  WANG Shenwu  WANG Debing
Abstract:Objective:To investigate whether multidrug resistance(mdrl)gene was associated with the failure of chemotherapy in acute leukemia. Methods:With human mdrl probe,the mdrl gene expresSion level of 30 cases of acute leukemia was analvzed by non-radioactive in situ hybridization(NISH). Result:The mdrl gene expression levels were higher in acute leukemia patients with no response to the chemotherapy and in relapsed state than in patients before treatment and in patients with complete re-mission after treatment(P<0.001,P<0.01,respectively).Conclusion:These data suggest that ele-vated expression levels of mdrl mRNA levels might be one of the causes of no response to chemothera-py. Overexpression of mdrl gene suggests poor responses in primary and relapsed acute leukemias.
Keywords:Gene expression  Drug tolerance  Leukemia/genet  
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号